In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1855 News Items found
Medical illustration of nanoparticle spheres attacking cancer cell, which is beginning to disintegrate.
In the Lab
Nanoparticles Help Drugs Target Head and Neck Cancers with Reduced Side Effects

Researchers devised a novel method to ferry drugs to head and neck cancers using nanoparticles that naturally stick to a protein in tumor blood vessels.
Histology images of stem cells and AML cells
In the Lab
Step by Step: Stem Cell Approach Provides New Models for Studying How Acute Myeloid Leukemia Progresses

A new laboratory tool will allow researchers to study the progression from normal cells to myelodysplastic syndromes to an aggressive type of leukemia.
Pancreatic beta cells
In the Lab
Connecting the Dots: Stem Cells Provide Valuable Tool for Linking Genes and Disease

Researchers are using pluripotent stem cells to create models of diabetes and pancreatic cancer.
Lymphedema can produce uncomfortable swelling in the arms or legs in the months and years following cancer treatment.
In the Lab
Could a Topical Cream Prevent Lymphedema? Study in Mice Suggests Yes

By blocking a source of inflammation in the skin, it may be possible to prevent or treat lymphedema, a common and debilitating cancer complication.
MSK scientists Charles Rudin and John Poirier
In the Lab
Scientists Home in on Treatment Advance for Chemotherapy-Resistant Small Cell Lung Cancer

An epigenetic mechanism may make small cell lung cancer vulnerable to a new kind of attack.
Pathology slide showing DCIS and invasive cancer
In the Lab
Forensic Techniques Enable Study of Individual Breast Cancer Cells from MSK’s Archives

Analysis of long-preserved single cells on pathology slides aims to provide new clues about the genes that make breast cancer more aggressive.
Barry Taylor
Feature
With MSK Leading the Way, Precision Medicine Links Lab Research to Patient Care

Therapies that target genetic alterations in tumors are showing promise for many cancer patients, but challenges in developing these new treatments remain.
Woman giving presentation at work
Finding
Study Highlights Workplace Difficulties Some Women Face During Cancer Treatment

Discover the role of the work environment in the life and career of an employee with cancer.
Memorial Sloan Kettering Researcher Examines Disparity in Job Retention in Breast Cancer Patients

Breast cancer affects one in eight women in the United States, with approximately 70 to 80 percent of employed breast cancer survivors returning to work three to eighteen months following diagnosis. Job loss can have devastating financial consequences, including increased risk of bankruptcy and debt. Victoria Blinder, MD, medical oncologist at Memorial Sloan Kettering, conducted a longitudinal study of a racially and ethnically diverse sample of employed women undergoing treatment for stage I-III breast cancer in New York City. For more information on this study, published in <i>Health Affairs</i> on February 6, 2017, and to speak with the study author, contact [email protected].
Lucy Kalanithi gestures while speaking. Physicians in white lab coats look on.
Support
When Breath Becomes Air: Dr. Lucy Kalanithi Reflects on How Cancer Changed Her Family’s Life

Read a Q & A with Lucy Kalanithi, the widow of Paul Kalanithi, who wrote When Breath Becomes Air.